# Human Umbilical Cord Mesenchymal Stem Cells for Alport Syndrome

> **NCT06731192** · PHASE2,PHASE3 · NOT_YET_RECRUITING · sponsor: **Guangzhou Women and Children's Medical Center** · enrollment: 40 (estimated)

## Conditions studied

- Alport Syndrome

## Interventions

- **BIOLOGICAL:** hUC-MSC
- **DRUG:** Placebo control drug

## Key facts

- **NCT ID:** NCT06731192
- **Lead sponsor:** Guangzhou Women and Children's Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-01-01
- **Primary completion:** 2026-06-30
- **Final completion:** 2028-12-31
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2024-12-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06731192

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06731192, "Human Umbilical Cord Mesenchymal Stem Cells for Alport Syndrome". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06731192. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*